64x Bio nets $55m Series A

64x Bio, a synthetic biology company, has raised $55 million in Series A financing.

64x Bio, a synthetic biology company, has raised $55 million in Series A financing. Lifeforce Capital led the round with participation from other investors that include Northpond Ventures, Future Ventures, and First Round Capital.

Source: Press Release